Ohtuvayre Side Effects

Generic name: ensifentrine

Medically reviewed by Drugs.com. Last updated on Jan 10, 2025.

Note: This document provides detailed information about Ohtuvayre.

Applies to ensifentrine: oral inhalation inhalation suspension Side Effects associated with ensifentrine. Some dosage forms listed on this page may not apply specifically to the brand name Ohtuvayre.

Applies to ensifentrine: oral inhalation inhalation suspension.

Side effects include:

Most common adverse reactions (≥1%): back pain, hypertension, urinary tract infection, diarrhea.

For healthcare professionals

Applies to ensifentrine: inhalation suspension.

General adverse events

The most frequently reported side effects (incidence greater and equal to 1% and more common than placebo) included back pain, diarrhea, hypertension, and urinary tract infection.^[Ref]

Cardiovascular

• Common (1% to 10%): Hypertension^[Ref]

Gastrointestinal

• Common (1% to 10%): Diarrhea^[Ref]

Genitourinary

• Common (1% to 10%): Urinary tract infection^[Ref]

Musculoskeletal

• Common (1% to 10%): Back pain^[Ref]

Psychiatric

• Uncommon (0.1% to 1%): Insomnia, anxiety, depression-related reactions (including depression, major depression, adjustment disorder with depressed mood)
• Frequency not reported: Psychiatric events, suicide-related adverse reactions (including suicide attempt, suicide)^[Ref]

Further information

Ohtuvayre side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer